{"id":"W4411040719","doi":"10.1111/ene.70222","title":"Glial Fibrillary Acidic Protein as a Marker of Disease in Relapsing Multiple Sclerosis: Post Hoc Analysis of Phase 3 Ozanimod Trials","year":2025,"lang":"en","type":"article","venue":"European Journal of Neurology","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"ca_institutions":"McGill University; NeuroRx Research (Canada)","funders":"Bristol-Myers Squibb","keywords":"Post-hoc analysis; Medicine; Glial fibrillary acidic protein; Expanded Disability Status Scale; Internal medicine; Multiple sclerosis; Glatiramer acetate; Oncology; Disease; Immunology; Immunohistochemistry","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0211689,0.001624761,0.004103501,0.0005092521,0.0004553396,0.001555129,0.0009932735,0.0009252403,0.004230999],"category_scores_gemma":[0.01891421,0.0004673777,0.008296517,0.0008020435,0.0007249553,0.001347937,0.001080824,0.002310059,0.0004679497],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007218018,"about_ca_system_score_gemma":0.001925218,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000624918,"about_ca_topic_score_gemma":0.001359093,"domain_scores_codex":[0.9865862,0.009295529,0.0008208455,0.00142495,0.0008898029,0.0009826719],"domain_scores_gemma":[0.9774917,0.01334088,0.004679944,0.002157246,0.001424931,0.0009054218],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"observational","study_design_scores_codex":[0.8787403,0.001166157,0.03363689,0.003146732,0.05896344,0.0001672407,0.0002643954,0.001258615,0.003753828,0.0003084084,0.002517089,0.01607691],"study_design_scores_gemma":[0.2131723,0.2331023,0.3763951,0.0009671503,0.138743,0.0005370229,0.0004475238,0.008051929,0.008508952,0.002272523,0.01756485,0.0002373648],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9755736,0.008813055,0.003650924,0.0005273953,0.0006151095,0.003768998,0.004071397,0.00019915,0.002780401],"genre_scores_gemma":[0.9852725,0.0008602656,0.003570745,0.0004322586,0.0002013919,0.00621557,0.00178653,0.0001229438,0.001537741],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.0211689,"threshold_uncertainty_score":0.1119532,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.07840716428536698,"score_gpt":0.3527805513442977,"score_spread":0.2743733870589307,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}